Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

DUALITYBIO-B

406.400
+3.6000.89%
Volume:917.50K
Turnover:380.22M
Market Cap:35.78B
PE:-2.83
High:433.000
Open:410.400
Low:405.000
Close:402.800
52wk High:433.800
52wk Low:165.500
Shares:88.04M
HK Float Shares:88.04M
Volume Ratio:0.98
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-143.741
ROE:--
ROA:-6.51%
PB:11.22
PE(LYR):-2.83
PS:15.06

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
DUALITYBIO-B
Exchange:
SEHK
Establishment Date:
2019
Employees:
191
Office Location:
Full floor, 11th Floor,Tower A, Datang International Plaza,China Construction Engineering Group,No. 868 Yinghua Road, Pudong New Area,Shanghai,Shanghai Province,China
Website:
http://www.dualitybiologics.com
Zip Code:
- -
Phone:
86 21 2601 8730
Fax:
- -
Introduction:
Duality Biotherapeutics Inc is an investment holding company principally engaged in clinical-stage biopharmaceuticals. The Company is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The Company's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The Company's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The Company principally conducts its businesses in domestic and overseas markets.

Directors

Name
Position
ZHU Zhong Yuan
Chairman of the Board,Executive Director,Chairman of the Nomination Committee
ZHANG Shao Ren
Executive Director
SI Wen
Executive Director,Member of the Remuneration and Assessment Committee
XIE Dong
Independent Director,Member of the Nomination Committee,Chairman of the Audit Committee
GAO Feng Yong
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Audit Committee
CHUAI Shu Yin
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Member of the Audit Committee
CAI Zhi Yang
Director
YU Tao
Director

Shareholders

Name
Position
ZHU Zhong Yuan
CEO
HUA Hai Qing
Vice General Manager,Other Senior Executives
YU Xin
Vice General Manager,Other Senior Executives
CENG Ying Wen
Corporate Secretary
YUAN Jia Li
Corporate Secretary,Other Senior Executives
WANG Xin
Chief Business Officer
QIU Yang
Chief Science Officer
ZHANG Shao Ren
Other Senior Executives
SI Wen
Other Senior Executives
GU Wei
Other Senior Executives
SHI Rong
Other Senior Executives
CHU Ruiyin
Other Senior Executives
ZHOU Lan
Other Senior Executives
MOU Hua
Other Senior Executives